Evidence map›Paper›PMID 31787999›Full record

ArticleFrontiers in genetics2019

Mutations in

Zhiwei Qiao, Ying Jiang, Ling Wang, Lei Wang, Jing Jiang, Jingru Zhang

Abstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Article
  4. Elucidating the role ofFrontiers in immunology · 2025
    Article
  5. Review
  6. Article
  7. METTL3-dependent mCell death & disease · 2023
    Article
  8. AKAP13 Enhances CREB1 Activation by FSH in Granulosa Cells.Reproductive sciences (Thousand Oaks, Calif.) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. An interactive analysis of the mouse oviductal miRNA profiles.Frontiers in cell and developmental biology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Cancer management and research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiwei QiaoThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.
Ying JiangThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.
Ling WangThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.
Lei WangThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.
Jing JiangThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.
Jingru ZhangThe Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shengyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer (EC) is one of the most common gynecologic malignancies. Emerging studies had demonstrated the mutations in genes could serve as diagnostic or prognostic markers for human cancers. In this study, we screened mutated genes in EC and found that the mutations in

Indexed as

bioinformatics analysesbiomarkersendometrial cancermutationoverall survival time

Identifiers

PMID31787999
PMCPMC6854026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.